Clinical Trial Update: Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold [Phase 3]

View source ↗

Summary

Phase 3 trial results update on the decongestant effectiveness, onset of action, and impact on sleep and general well-being of xylometazoline in individuals wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• Xylometazoline (Xylometazoline)

Snippet

Sponsor: Novartis | Conditions: Common Cold | Phase 3 | Status: COMPLETED